Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: Blood compatibility evaluation and targeted drug delivery onto cancer cells

Journal of Colloid and Interface Science

Volumn 368, Issue 1, 2012, Pages 144-151

  Manju, S ^a   Sreenivasan, K ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Folic acid conjugated polyethylene glycol; Gold nanoparticle; Hemocompatibility; Hyaluronic acid; Water soluble curcumin

Indexed keywords

ANALYTICAL TECHNIQUES; ANTI-TUMOR ACTIVITIES; ANTICANCER ACTIVITIES; AQUEOUS SOLUBILITY; BLOOD COMPATIBILITY; BLOOD-COMPATIBLE; CACO-2 CELLS; CANCER CELL LINES; CANCER CELLS; CELLULAR UPTAKE; CHLOROAURIC ACID; CURCUMIN; DUAL ROLE; FUNCTIONALIZED; GOLD NANOPARTICLE; GOLD NANOPARTICLES; HELA CELL; HEMOCOMPATIBILITY; HYALURONIC ACID; HYALURONIC ACIDS; IN-VIVO; NANOCARRIERS; SIMPLE METHOD; STABILIZING AGENTS; TARGETED DRUG DELIVERY; TUMOR SITE; WATER SOLUBLE CURCUMIN; WATERSOLUBLE;

BIOCHEMISTRY; BLOOD; CELL CULTURE; CONFOCAL MICROSCOPY; DISEASES; DRUG DELIVERY; FLOW CYTOMETRY; GLYCOLS; GOLD; NANOPARTICLES; ORGANIC ACIDS; POLYETHYLENE GLYCOLS;

CELLS;

CURCUMIN; GOLD NANOPARTICLE; HYALURONIC ACID; POLYMER;

ARTICLE; BLOOD COMPATIBILITY; CANCER CELL; CELL STRAIN CACO 2; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG TARGETING; DRUG UPTAKE; FEMALE; FLOW CYTOMETRY; GLIOMA CELL; HELA CELL; HUMAN; HUMAN CELL; NANOFABRICATION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; BLOOD COAGULATION; CELL PROLIFERATION; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; GOLD; HELA CELLS; HUMANS; HYALURONIC ACID; MAGNETICS; MEMBRANES, ARTIFICIAL; METAL NANOPARTICLES; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES; TUMOR CELLS, CULTURED; WATER;

EID: 84855856570     PISSN: 00219797     EISSN: 10957103     Source Type: Journal    
DOI: 10.1016/j.jcis.2011.11.024     Document Type: Article

References (39)

1. Moorthi C., Manavalan R., Kathiresan K. J. Pharm. Pharmaceut. Sci. 2011, 14:67-77.
2. Alexis F., Pridgen E., Molnar L.K., Farokhzad O.C. Mol. Pharm. 2008, 5:505-515.
3. Shyh-Dar Li, Huang L. Mol. Pharm. 2008, 5:496-504.
4. Gelperina S. Am. J. Respir. Crit. Care Med. 2005, 172:1487-1490.
5. Giljohann D.A., Seferos D.S., Daniel W.L., Massich M.D., Patel P.C., Mirkin C.A. Angew. Chem. Int. Ed. 2010, 49:3280-3295.
6. Lee K., Lee H., Bae Ki H., Park T.G. Biomaterials 2010, 31:6530-6536.
7. Chen Y.H., Tsai C.Y., Huang P.Y., Chang M.Y., Cheng P.C., Chou C.H., et al. Mol. Pharmaceut. 2007, 4:713-722.
8. Gibson J.D., Khanal B.P., Zubarev E.R. J. Am. Chem. Soc. 2007, 129:11653-11661.
9. Venkatpurwar V., Shiras A., Pokharkar V. Int. J. Pharmaceut. 2011, 409:314-320.
10. Liang M., Lin I.C., Whittaker M.R., Minchin R.F., Monteiro M.J., Toth I. ACS Nano 2010, 4:403-413.
11. Sharma O.P. Biochem. Pharmacol. 1976, 25:1811-1812.
12. Aggarwal B.B., Kumar A., Bharti A.C. Anticancer Res. 2003, 23:363-398.
13. Ramachandran, You C.W. Breast Cancer Res. Treat. 1999, 54:269-278.
14. Ishita C., Kaushik B., Uday B., Ranajit K.B. Curr. Sci. 2004, 87:44-53.
15. Tuttle S., Hertan L., Katz J.S. Cancer Biol. Ther. 2011, 11:474-476.
16. Tomita M., Kawakami H., Uchihara J.N., Okudaira T., Masuda M., Takasu N., et al. Int. J. Cancer 2006, 118:765-772.
17. Aggarwal B.B., Shishodia S. Biochem. Pharmacol. 2006, 71:1397-1421.
18. Arbiser J.L., Klauber N., Rohan R., et al. Mol. Med. 1998, 4:376-383.
19. Kawamori T., Lubet R., Steele V.E., Kelloff G.J., Kaskey R.B., Rao C.V., et al. Cancer Res. 1999, 59:597-601.
20. Bava S.V., Puliappadamba V.T., Deepti A., Nair A., Karunagaran D., Anto R.J. J. Biol. Chem. 2005, 280:6301-6308.
21. Chan M.M., Fong D., Soprano K.J., Holmes W.F., Heverling H. J. Cell Physiol. 2003, 194:63-70.
22. Notarbartolo M., Poma P., Perri D., Dusonchet L., Cervello M., D'Alessandro N. Cancer Lett. 2005, 224:53-65.
23. Wang Y.J., Pan M.H., Cheng A.L., Lin L.I., Ho Y.S., Hsieh C.Y., et al. J. Pharm. Biomed. Anal. 1997, 15:1867-1876.
24. Sharma R.A., Euden S.A., Platton S.L., Cooke D.N., Shafayat A., Hewitt H.R., et al. Clin. Cancer Res. 2004, 10:6847-6854.
25. Huang M.T., Newmark H.L., Frenkel K. J. Cell. Biochem. Suppl. 1997, 27:26-34.
26. Safavy A., Raisch K.P., Mantena S., Sanford L.L., Sham S.W., Krishna N.R., et al. J. Med. Chem. 2007, 50:6284-6288.
27. Manju S., Sreenivasan K. J. Colloid Interface Sci. 2011, 359:318-325.
28. Maeda H., Seymou L.W., Miyamoto Y. Bioconjugate Chem. 1992, 3:351-362.
29. Laurent T.C. Acta Otolaryngol. Suppl. 1987, 442:7-24.
30. Fraser J.R., Laurent T.C., Laurent U.B. J. Intern. Med. 1997, 242:27-33.
31. Herrlich P., Leeman J., Wainwright D., Konig H., Sherman L., Ponta H. Cell Adhes. Commun. 1998, 6:141-147.
32. Hall C.L., Yang B., Yang X., Zhang S., Turley M., Samuel S., et al. Cell 1995, 82:19-28.
33. Lee H., Mok H., Lee S., Oh Y.K., Park T.G. J. Control. Release 2007, 119:245-252.
34. Zheng Y., Cai Z., Song X., Chen Q., Bi Y., Li Y., et al. J. Drug Target 2009, 17:294-303.
35. Xia W., Low P.S. J. Med. Chem. 2010, 53:6811-6824.
36. Babic M., Horak D., Jendelova P., Glogarova K., Herynek V., Trchova M., et al. Bioconjugate Chem. 2009, 20:283-294.
37. Lee D.W., Powers K., Baney R. Carbohydr. Polym. 2004, 58:371-377.
38. Turkevich J., Stevenson P.C., Hillier J. J. Phys. Chem. 1953, 57:670-673.
39. Liao H., Hafner J.H. Chem. Mater. 2005, 17:4636-4641.